Advertisement
Canada markets closed

  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    87,473.99
    -1,430.20 (-1.61%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.92%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     

  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT RESULTS

Chevron, Exxon under pressure as falling natural gas prices hit earnings

Khiron Life Sciences Added to ETFMG Alternative Harvest ETF

ME Staff

Khiron Life Sciences (TSXV: KHRN) (OTCQB: KHRNF), a cannabis company with core operations in Latin America, said that it has been added the MJ ETFMG Alternative Harvest ETF (NYSE: MJ), a fund with approximately US$1.22 billion in assets currently under management.

The company calls it an important development as it advances its strategy as a Latin American cannabis company with global growth.

The ETFMG Alternative Harvest ETF tracks the Prime Alternative Harvest Index, designed to measure the performance of companies within the cannabis ecosystem benefiting from global medicinal and recreational cannabis legalization.

The fund seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Alternative Harvest Index.

ADVERTISEMENT

As of May 28, the fund held approximately 4.2 million Khiron Life Sciences common shares. A rebalancing of the fund occurs each calendar quarter.

Khiron Bullish On Latin American Market

Khiron is positioned to be the dominant integrated cannabis company in Latin America. The company has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis

In May 2018, Khiron listed on the TSXV, becoming the first Colombian based medical cannabis company to trade on any exchange globally.

The company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people.

The post Khiron Life Sciences Added to ETFMG Alternative Harvest ETF appeared first on Market Exclusive.